Alison A Cornell has bought ZIVO on 4 days since Jun 2021

Alison A. Cornell is an independent Director at Zivo Bioscience, Inc. (ZIVO), serving since February 2021.( Aged 63 and currently retired, she chairs the Audit Committee (where she is designated the Board's "audit committee financial expert"), chairs the Compensation Committee, and serves on the Nominating and Corporate Governance Committee.( On January 26, 2026, she purchased 11,709 shares at $8.54 each, increasing her direct ownership to 279,481 shares.(

Cornell brings extensive executive finance experience, including roles as Executive Vice President & Chief Financial Officer at Compassion-First Pet Hospitals (July 2017–2021), International Flavors & Fragrances Inc. (IFF) (July 2015–October 2016), and multiple positions at Covance, Inc., culminating as Corporate SVP & CFO (2004–July 2015).( A certified Treasury Professional with early career experience at AT&T, she also serves as Director and Audit Committee Chair at Chou2 Pharma and is committed to women's leadership development.( She holds significant equity in ZIVO (7.2% as of recent data), aligning her interests with shareholders.(

Written by Perplexity from public sources.